IMA Advisory Services’s 10x Genomics TXG Stock Holding History

IMA Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153	Sell	4 -14	-78%	-$367	﹤0.01%	1356
2026 Q1	$382	Hold	18	–	–	﹤0.01%	894
2025 Q4	$293	Hold	18	–	–	﹤0.01%	909
2025 Q3	$210	Hold	18	–	–	﹤0.01%	493
2025 Q2	$208	Buy	+18	New	+$164	﹤0.01%	488

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IMA Advisory Services's TXG Position: Q2 2026 in Review

IMA Advisory Services reduced its 10x Genomics (TXG) stake by 78% in Q2 2026, selling an estimated $367 and leaving 4 shares worth $153. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

IMA Advisory Services first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. The position peaked at $382 in Q1 2026. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

IMA Advisory Services held 4 shares of 10x Genomics worth $153 as of Q2 2026.
IMA Advisory Services sold 14 10x Genomics shares in Q2 2026, an estimated $367.
10x Genomics made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #1356 holding.
IMA Advisory Services first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
IMA Advisory Services's 10x Genomics position peaked at $382 in Q1 2026.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.